内皮细胞种子细胞的来源和应用:一篇综述
Dan Deng1, Yu Zhang1, Bo Tang2
1Department of Cardiovascular Medicine, Center for Circadian Metabolism and Cardiovascular Disease, Southwest Hospital, Army Medical University, Chongqing, China.
Stem cell research & therapy
|June 17, 2024
概括
本综述探讨了用于组织工程和疾病建模的多种内皮细胞 (EC) 来源. 它指导研究人员选择最佳的EC来源进行临床前研究和临床翻译.
科学领域:
- 生物医学工程 生物医学工程
- 细胞生物学 细胞生物学
- 再生医学是一种再生医学.
背景情况:
- 内皮细胞 (ECs) 在组织工程,有机体发育和疾病建模中对血管化至关重要.
- 在缺血性疾病中,EC对于恢复血管至关重要,从而改善治疗结果.
- 目前的研究利用了各种EC来源,包括干细胞,初级细胞和细胞系转换.
研究的目的:
- 提供当前内皮细胞 (EC) 源的全面概述.
- 讨论与每个EC源相关的特点,应用和挑战.
- 引导选择合适的EC来源用于临床前研究和临床翻译.
主要方法:
- 关于内皮细胞来源的现有研究的文献综述.
- 分析不同EC类型的特性和应用.
- 确定EC使用的挑战和缓解策略.
主要成果:
- 干细胞/祖细胞,初级EC和其他EC来源的详细比较.
- 了解各种EC在再生医学和疾病建模中的潜在应用.
- 确定EC采购的关键挑战和改进策略.
结论:
- 选择合适的内皮细胞 (EC) 源对于成功的组织工程和治疗应用至关重要.
- 解决欧盟采购的当前挑战将加速将研究转化为临床实践.
- 这篇综述是研究人员和临床医生用内皮细胞工作的宝贵参考资料.
相关概念视频
Mechanism of Angiogenesis
6.4K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
6.4K
Regulation of Angiogenesis and Blood Supply
2.9K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.9K
Clinical Applications of Epidermal Stem Cells
2.4K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.4K


